---
id: ISO22442-1-2015
type: standard
schema_version: v1.4.1
title:
- language: en
  script: Latn
  content: Medical devices utilizing animal tissues and their derivatives
  type: title-main
  format: text/plain
- language: en
  script: Latn
  content: 'Part 1: Application of risk management'
  type: title-part
  format: text/plain
- language: en
  script: Latn
  content: 'Medical devices utilizing animal tissues and their derivatives - Part
    1: Application of risk management'
  type: main
  format: text/plain
- language: fr
  script: Latn
  content: Dispositifs médicaux utilisant des tissus animaux et leurs dérivés
  type: title-main
  format: text/plain
- language: fr
  script: Latn
  content: 'Partie 1: Application de la gestion des risques'
  type: title-part
  format: text/plain
- language: fr
  script: Latn
  content: 'Dispositifs médicaux utilisant des tissus animaux et leurs dérivés - Partie
    1: Application de la gestion des risques'
  type: main
  format: text/plain
source:
- type: src
  content: https://www.iso.org/standard/68553.html
- type: rss
  content: https://www.iso.org/contents/data/standard/06/85/68553.detail.rss
docidentifier:
- content: ISO 22442-1:2015
  type: ISO
  primary: true
- content: ISO 22442-1:2015(E)
  type: iso-reference
- content: urn:iso:std:iso:22442:-1:stage-95.99
  type: URN
docnumber: '22442'
date:
- type: published
  at: 2015-11
contributor:
- role:
  - type: publisher
  organization:
    uri:
    - content: www.iso.org
    name:
    - content: International Organization for Standardization
    abbreviation:
      content: ISO
edition:
  content: '2'
language:
- en
- fr
script:
- Latn
abstract:
- language: en
  script: Latn
  content: |-
    ISO 22442-1:2015 applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing materials of animal origin, which are non-viable or have been rendered non-viable. It specifies, in conjunction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for the residual risk acceptability, taking into account the balance of residual risk, as defined in ISO 14971, and expected medical benefit as compared to available alternatives. This part of ISO 22442 is intended to provide requirements and guidance on risk management related to the hazards typical of medical devices manufactured utilizing animal tissues or derivatives such as
    a)   contamination by bacteria, moulds or yeasts;
    b)   contamination by viruses;
    c)   contamination by agents causing Transmissible Spongiform Encephalopathies (TSE);
    d)   material responsible for undesired pyrogenic, immunological or toxicological reactions.
    For parasites and other unclassified pathogenic entities, similar principles can apply.
    ISO 22442-1:2015 does not stipulate levels of acceptability which, because they are determined by a multiplicity of factors, cannot be set down in such an International Standard except for some particular derivatives mentioned in Annex C. Annex C stipulates levels of TSE risk acceptability for tallow derivatives, animal charcoal, milk and milk derivatives, wool derivatives and amino acids.
    ISO 22442-1:2015 does not specify a quality management system for the control of all stages of production of medical devices.
    ISO 22442-1:2015 does not cover the utilization of human tissues in medical devices.
    NOTE 1       It is not a requirement of this part of ISO 22442 to have a full quality management system during manufacture. However, attention is drawn to International Standards for quality management systems (see ISO 13485) that control all stages of production or reprocessing of medical devices.
    NOTE 2       For guidance on the application of this part of ISO 22442, see Annex A.
- language: fr
  script: Latn
  content: |-
    L'ISO 22442-1:2015 s'applique aux dispositifs médicaux autres que les dispositifs médicaux de diagnostic in vitro, dans la fabrication desquels entrent des matériaux d'origine animale non viables ou rendus non viables. Associée à l'ISO 14971, elle spécifie un mode opératoire permettant d'identifier les dangers et les situations dangereuses associés à de tels dispositifs, d'estimer et d'évaluer les risques qui en découlent, de maîtriser ces risques et de surveiller l'efficacité de cette maîtrise. En outre, elle décrit le processus décisionnel relatif à l'acceptabilité du risque résiduel, en tenant compte du rapport entre le risque résiduel, tel que défini dans l'ISO 14971, et le bénéfice médical escompté par rapport aux solutions de remplacement disponibles. L'ISO 22442-1:2015 est destinée à fournir des exigences et des lignes directrices pour la gestion des risques associée aux dangers typiques des dispositifs médicaux dans la fabrication desquels entrent des tissus ou des dérivés d'origine animale, notamment:
    a)    la contamination par des bactéries, des moisissures ou des levures;
    b)    la contamination par des virus;
    c)    la contamination par des agents responsables d'encéphalopathies spongiformes transmissibles (EST);
    d)    un matériau provoquant des réactions pyrogènes, immunologiques ou toxicologiques indésirables.
status:
  stage:
    content: '95'
  substage:
    content: '99'
copyright:
- from: '2015'
  owner:
  - organization:
      name:
      - content: ISO
relation:
- type: obsoletes
  bibitem:
    type: standard
    formattedref: ISO 22442-1:2007
    docidentifier:
    - content: ISO 22442-1:2007
      type: ISO
      primary: true
- type: updates
  bibitem:
    type: standard
    formattedref: ISO 22442-1:2020
    docidentifier:
    - content: ISO 22442-1:2020
      type: ISO
      primary: true
    date:
    - type: circulated
      at: '2020-09-15'
place:
- formatted_place: Geneva
ext:
  schema_version: v1.0.5
  doctype:
    content: international-standard
  flavor: iso
  editorialgroup:
    technical_committee:
    - number: 194
      type: TC
      identifier: ISO/TC 194
      content: Biological and clinical evaluation of medical devices
  ics:
  - code: 11.100.20
    text: Biological evaluation of medical devices
  structuredidentifier:
    type: ISO
    project_number:
      content: '68553'
